QUIPS risk of bias assessment. by Nabeela Arbee-Kalidas (17598969)

“…Higher estimates of peak, measured and as a percentagege of predicted, showed significant associations with a lower risk of mortality [MD: 3.66, 95% CI: 0.88; 6.43 and MD: 16.49, 95% CI: 6.92; 26.07] and fewer complications [MD: 2.06, 95% CI: 1.12; 3.00 and MD: 9.82, 95% CI: 5.88; 13.76]. …”

The trend of risk scores. by Ayako Shoji (78037)

Engagement of monocytes, NK cells, and CD4⁺ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIV_mac251 vaginal acquisition by Giacomo Gorini (5693312)

“…<div><p>The recombinant Canarypox ALVAC-HIV/gp120/alum vaccine regimen was the first to significantly decrease the risk of HIV acquisition in humans, with equal effectiveness in both males and females. …”

Flow Chart of Study Participant Selection. by Zhi Jin (3742471)

Subjects:

Model comparison results. by Giulia Priolo (10146494)

“…However, this effect is modulated by the experimental manipulation. Specifically, we detect a detrimental effect (i.e., a significant decrease in the intercept) of the disgust-eliciting image in Incongruent condition (vs. …”

Coefficient estimates (log-odds scale). by Giulia Priolo (10146494)

“…However, this effect is modulated by the experimental manipulation. Specifically, we detect a detrimental effect (i.e., a significant decrease in the intercept) of the disgust-eliciting image in Incongruent condition (vs. …”

Model comparison results. by Giulia Priolo (10146494)

“…However, this effect is modulated by the experimental manipulation. Specifically, we detect a detrimental effect (i.e., a significant decrease in the intercept) of the disgust-eliciting image in Incongruent condition (vs. …”

Discovery of Novel Oxazepine Derivatives as Akt/ROCK Inhibitors for Growth Arrest and Differentiation Induction in Neuroblastoma Treatment by Jinxin Che (791250)

“…Treatment with <b>B12</b> results in the arrest of G0/G1 cell cycles, a significant decrease in N-myc protein level, and an increase in differentiation markers. …”

Discovery of Novel Oxazepine Derivatives as Akt/ROCK Inhibitors for Growth Arrest and Differentiation Induction in Neuroblastoma Treatment by Jinxin Che (791250)

“…Treatment with <b>B12</b> results in the arrest of G0/G1 cell cycles, a significant decrease in N-myc protein level, and an increase in differentiation markers. …”

Discovery of Novel Oxazepine Derivatives as Akt/ROCK Inhibitors for Growth Arrest and Differentiation Induction in Neuroblastoma Treatment by Jinxin Che (791250)

“…Treatment with <b>B12</b> results in the arrest of G0/G1 cell cycles, a significant decrease in N-myc protein level, and an increase in differentiation markers. …”

Discovery of Novel Oxazepine Derivatives as Akt/ROCK Inhibitors for Growth Arrest and Differentiation Induction in Neuroblastoma Treatment by Jinxin Che (791250)

“…Treatment with <b>B12</b> results in the arrest of G0/G1 cell cycles, a significant decrease in N-myc protein level, and an increase in differentiation markers. …”

Densely Packed Chemical Synthesis Equipment by 3D Spatial Design and Additive Manufacturing: Acetylene Generation Cartridge by Kirill S. Erokhin (16061904)

Subjects:

Histidine-tryptophan-ketoglutarate solution decreases mortality and morbidity in high-risk patients with severe pulmonary arterial hypertension associated with complex congenital h... by X.W. Li (6546986)

“…Univariate and multivariate analysis showed that HTK is a statistically significant independent predictor of decreased early mortality and morbidity (P<0.05). …”

Factors related to risk scores. by Ayako Shoji (78037)

Variants with an unknown significance or conflicting interpretation of clinical significance. by J. Tyson McDonald (3687694)

Subjects:

S1 Graphical abstract - by Aman Goyal (19231397)

“…</p><p>Conclusions</p><p>Our analysis showed a significant decrease in mortality from paroxysmal tachycardia since 1999, although there has been a slight increase in recent years. …”

Analysis of risk factors for perioperative change in uroflowmetry parameters. by Yuta Takeshima (818627)

PRISMA flow diagram. by Zahra Ali Padhani (8959490)

Subjects:

Characteristics of included studies. by Zahra Ali Padhani (8959490)

Subjects:

Flow diagram of exam selection. by Atsushi Abe (9396077)

Subjects: